MedPath
HSA Approval

JASTINDA FILM COATED TABLETS 3MG/ 0.02MG

SIN14995P

JASTINDA FILM COATED TABLETS 3MG/ 0.02MG

JASTINDA FILM COATED TABLETS 3MG/ 0.02MG

April 28, 2016

LOTUS INTERNATIONAL PTE. LTD.

LOTUS INTERNATIONAL PTE. LTD.

Regulatory Information

HSA regulatory responsibility and product classification details

Regulatory Responsibility

RegistrantLOTUS INTERNATIONAL PTE. LTD.
Licence HolderLOTUS INTERNATIONAL PTE. LTD.

Product Classification

D
Drug Type
Therapeutic
F
Forensic Class
Prescription Only
HSA Singapore Classification

Formulation Information

TABLET, FILM COATED

ORAL

Medical Information

G03AA12

drospirenone and ethinylestradiol

Manufacturer Information

LOTUS INTERNATIONAL PTE. LTD.

Laboratorios León Farma S.A

Active Ingredients

Drospirenone

3.00 mg

Drospirenone

Ethinyl Estradiol Micronized

0.02 mg

Ethinylestradiol

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

JASTINDA FILM COATED TABLETS 3MG/ 0.02MG - HSA Approval | MedPath